Search


 
Results 41 - 48 of about 48 for "From ACP Internist Weekly".

GLP-1 agonist plus basal insulin beat other diabetes treatment ...

Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain ...

Lifestyle modification may outperform medications over time ...

Twenty-five people would need to be treated with lifestyle modification to prevent one diabetes case, according to the analysis of randomized clinical ...

Ischemic heart disease linked to worse prognosis in heart ...

Mortality risk was highest in patients who had both type 2 diabetes and ischemic heart disease and had not had previous revascularization.

Physician volume linked to diabetes care quality, study finds ...

The researchers found that higher ambulatory volume overall was associated with lower rates of appropriate eye exams, HbA1c testing, and LDL cholesterol ...

Gastric bypass benefits persist over long-term follow-up, study ...

At 12 years, patients who underwent Roux-en-Y gastric bypass had significantly greater weight loss and lower risk of diabetes than those who didn't ...

ADA issues updated position statement on hypertension and ...

The statement updates the American Diabetes Association's 2003 position statement on this topic and summarizes clinical trials of intensive hypertension ...

GLP-1 analogues may be associated with bile duct ...

Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral ...

Exercise tips for type 1 diabetes offered by consensus ...

The consensus statement advises physicians about ways to manage people with type 1 diabetes who exercise regularly, including glucose targets for ...

In order to show you the most relevant results, we have omitted some entries very similar to the search results already displayed. If you like, you can repeat the search with the omitted results included.

Result Page: < Previous  1 2 3 4 5